Recordati SpA (RICFY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
Recordati SpA ( RICFY ) reported a 12% increase in net revenue for the first nine months of 2024, reaching 1.743 billion euros. The company achieved an EBITDA margin of 38.2%, reflecting strong profitability. Recordati SpA ( RICFY ) confirmed its full-year 2024 financial targets, which were upgraded in July, indicating confidence in continued business momentum. The acquisition of global rights to NJO from Sanofi is expected to contribute positively to EBITDA from 2025 onwards. Recordati SpA ( RICFY ) reported a robust free cash flow of 434.3 million euros, up 11% from the previous year. The company faced adverse effects in Turkey due to recent devaluation and timing of price increases, impacting growth. There is volatility in quarterly EBITDA margins due to seasonal factors and hyperinflation accounting in Turkey. The metabolic franchise experienced mild erosion in the US due to generic entries affecting Carbaglu. Recordati SpA ( RICFY ) anticipates higher financing e
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition [Yahoo! Finance]Yahoo! Finance
- HHS Must End Unauthorized Administration Of 340B Drug-Discount Program [Forbes]Forbes
- Sanofi/Regeneron Pharmaceuticals' DUPIXENT Approval Marks a Significant Shift in Chronic Obstructive Pulmonary Disease Treatment Landscape | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales [Yahoo! Finance]Yahoo! Finance
- CEO of pharma giant Sanofi says businesses should stop ‘AI washing' [Fortune]Fortune
SNY
Analyst Actions
- 9/19/24 - Citigroup Inc.
SNY
Sec Filings
- 11/7/24 - Form SC
- 11/7/24 - Form 6-K
- 10/31/24 - Form 6-K
- SNY's page on the SEC website